COF
55
-3
GM
65
-3
BMY
53
-7
MA
55
-7
UNH
61
6
CAG
30
4
DVA
72
2
NWS
62
-2
DOV
61
-2
MCO
73
3
PEP
41
6
AMAT
36
5
DD
56
3
QCOM
48
-7
BIIB
26
2
SYF
85
2
EL
20
3
CL
56
5
BEN
45
3
TGT
25
-24
COF
55
-3
GM
65
-3
BMY
53
-7
MA
55
-7
UNH
61
6
CAG
30
4
DVA
72
2
NWS
62
-2
DOV
61
-2
MCO
73
3
PEP
41
6
AMAT
36
5
DD
56
3
QCOM
48
-7
BIIB
26
2
SYF
85
2
EL
20
3
CL
56
5
BEN
45
3
TGT
25
-24
Financhill
Back

Syndax Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

SNDX
Syndax Pharmaceuticals

Last Price:
15.53
Seasonality Move:
13.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Syndax Pharmaceuticals Price Quote

$15.53
-0.42 (-2.63%)
(Updated: November 21, 2024 at 3:50 PM ET)

Syndax Pharmaceuticals Key Stats

Sell
23
Syndax Pharmaceuticals (SNDX) is a Sell
Day range:
$15.34 - $16.19
52-week range:
$14.97 - $25.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.75%
Volume:
1.3M
Avg. volume:
1.6M
1-year change:
3.44%
Market cap:
$1.4B
Revenue:
$0
EPS:
$-3.63

How Much Does Syndax Pharmaceuticals Make?

Data Unavailable

Is Syndax Pharmaceuticals Growing As A Company?

Data Unavailable

Syndax Pharmaceuticals Stock Price Performance

What Is Syndax Pharmaceuticals 52-Week High & Low?

Syndax Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Syndax Pharmaceuticals?

Is Syndax Pharmaceuticals Cash Flow Positive?

  • What Is SNDX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$258.9M
  • What Is Syndax Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $264.4M
  • What Is Syndax Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $32.9M

Syndax Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    SNDX return on invested capital is -67.33%
  • What Is Syndax Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -60.43%
  • What Is SNDX Return On Equity?
    ROE is a measure of profitability and is -67.33%

Syndax Pharmaceuticals Earnings Date & Stock Price

Syndax Pharmaceuticals Competitors

Syndax Pharmaceuticals Dividend Yield

Syndax Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.57%
Revenue: 0% 48.83%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 36.36
Upside from Last Price: 127.94%

Major Shareholders

  • How many SNDX shares are owned by institutional investors?
    132.7M SNDX shares are owned by institutional investors
  • How many SNDX shares are owned by insiders?
    812.3K SNDX shares are owned by insiders